Qiang Fu
Concepts (498)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fish Proteins | 3 | 2025 | 7 | 2.910 |
Why?
| Fishes | 3 | 2025 | 22 | 2.870 |
Why?
| Urethra | 3 | 2025 | 91 | 2.740 |
Why?
| Osteoblasts | 11 | 2025 | 462 | 2.230 |
Why?
| Fish Diseases | 3 | 2025 | 6 | 2.190 |
Why?
| Perciformes | 2 | 2025 | 3 | 1.960 |
Why?
| Osteoclasts | 11 | 2024 | 427 | 1.760 |
Why?
| Animals | 59 | 2025 | 13124 | 1.700 |
Why?
| Bone Resorption | 7 | 2024 | 302 | 1.620 |
Why?
| Somatostatin | 4 | 2014 | 31 | 1.560 |
Why?
| RANK Ligand | 13 | 2024 | 187 | 1.450 |
Why?
| Carrier Proteins | 7 | 2015 | 298 | 1.430 |
Why?
| Mice | 43 | 2025 | 5687 | 1.380 |
Why?
| Vitamin E | 6 | 2020 | 78 | 1.270 |
Why?
| Oxidative Stress | 8 | 2025 | 772 | 1.200 |
Why?
| Hydrogels | 2 | 2024 | 17 | 1.180 |
Why?
| Chromans | 5 | 2014 | 35 | 1.160 |
Why?
| Wound Healing | 3 | 2024 | 186 | 1.150 |
Why?
| Tissue Scaffolds | 2 | 2024 | 36 | 1.140 |
Why?
| Primary Ovarian Insufficiency | 2 | 2024 | 5 | 1.140 |
Why?
| Radiation-Protective Agents | 7 | 2020 | 72 | 1.130 |
Why?
| Cell-Derived Microparticles | 2 | 2017 | 20 | 1.040 |
Why?
| Recombinant Fusion Proteins | 4 | 2014 | 179 | 1.040 |
Why?
| Cathepsin D | 1 | 2025 | 4 | 0.980 |
Why?
| Cathepsin B | 1 | 2025 | 6 | 0.980 |
Why?
| Serum Albumin | 3 | 2014 | 57 | 0.980 |
Why?
| Solubility | 2 | 2024 | 71 | 0.980 |
Why?
| Music Therapy | 1 | 2025 | 3 | 0.980 |
Why?
| Osteocytes | 4 | 2025 | 224 | 0.980 |
Why?
| Chemokine CXCL12 | 1 | 2025 | 33 | 0.950 |
Why?
| Urethral Stricture | 1 | 2025 | 21 | 0.950 |
Why?
| Tissue Engineering | 2 | 2024 | 66 | 0.940 |
Why?
| Atenolol | 1 | 2024 | 13 | 0.940 |
Why?
| Depression, Postpartum | 1 | 2025 | 43 | 0.940 |
Why?
| Urologic Surgical Procedures, Male | 1 | 2025 | 40 | 0.940 |
Why?
| Biological Availability | 2 | 2024 | 102 | 0.940 |
Why?
| Theca Cells | 1 | 2024 | 1 | 0.940 |
Why?
| Neuronal Plasticity | 1 | 2025 | 58 | 0.940 |
Why?
| Cicatrix | 1 | 2024 | 40 | 0.930 |
Why?
| Mitochondrial Dynamics | 1 | 2024 | 21 | 0.920 |
Why?
| Pichia | 3 | 2014 | 8 | 0.920 |
Why?
| Temperature | 1 | 2025 | 162 | 0.910 |
Why?
| Bariatric Surgery | 1 | 2025 | 42 | 0.910 |
Why?
| Ultrasonography, Interventional | 1 | 2025 | 137 | 0.880 |
Why?
| Inflammation | 3 | 2025 | 610 | 0.880 |
Why?
| Rats, Sprague-Dawley | 4 | 2024 | 1585 | 0.870 |
Why?
| Thalidomide | 1 | 2025 | 378 | 0.820 |
Why?
| Laparoscopy | 1 | 2025 | 173 | 0.820 |
Why?
| Osteoporosis, Postmenopausal | 2 | 2025 | 30 | 0.790 |
Why?
| Osteogenesis | 4 | 2025 | 356 | 0.780 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2025 | 573 | 0.770 |
Why?
| Mice, Inbred C57BL | 15 | 2025 | 1808 | 0.710 |
Why?
| Disease Models, Animal | 5 | 2025 | 1436 | 0.690 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2014 | 138 | 0.690 |
Why?
| Anti-Bacterial Agents | 2 | 2025 | 745 | 0.690 |
Why?
| Cell Differentiation | 5 | 2024 | 640 | 0.610 |
Why?
| Gene Expression Regulation | 7 | 2025 | 955 | 0.610 |
Why?
| Immunity, Innate | 4 | 2025 | 105 | 0.590 |
Why?
| Postoperative Complications | 2 | 2025 | 1033 | 0.580 |
Why?
| Apoptosis | 6 | 2025 | 1097 | 0.580 |
Why?
| Whole-Body Irradiation | 7 | 2021 | 132 | 0.570 |
Why?
| Imipramine | 1 | 2017 | 13 | 0.570 |
Why?
| Myocardium | 1 | 2019 | 445 | 0.550 |
Why?
| Mitochondria | 4 | 2025 | 399 | 0.540 |
Why?
| Cell Line | 8 | 2024 | 988 | 0.540 |
Why?
| Intestinal Mucosa | 5 | 2021 | 216 | 0.530 |
Why?
| Radiation Injuries, Experimental | 3 | 2019 | 80 | 0.530 |
Why?
| Bone Density Conservation Agents | 1 | 2017 | 74 | 0.530 |
Why?
| Male | 30 | 2025 | 25913 | 0.520 |
Why?
| Humans | 40 | 2025 | 50516 | 0.520 |
Why?
| MicroRNAs | 1 | 2019 | 344 | 0.510 |
Why?
| Parathyroid Hormone | 7 | 2017 | 149 | 0.510 |
Why?
| Bone Remodeling | 2 | 2015 | 149 | 0.510 |
Why?
| Subcellular Fractions | 1 | 2015 | 33 | 0.500 |
Why?
| Intestines | 6 | 2021 | 172 | 0.500 |
Why?
| Agglutination | 2 | 2025 | 3 | 0.490 |
Why?
| Aeromonas salmonicida | 2 | 2025 | 4 | 0.490 |
Why?
| Membrane Glycoproteins | 4 | 2006 | 245 | 0.490 |
Why?
| Cell Communication | 1 | 2015 | 68 | 0.470 |
Why?
| Escherichia coli | 3 | 2024 | 190 | 0.470 |
Why?
| Mevalonic Acid | 1 | 2014 | 5 | 0.460 |
Why?
| Chitosan | 2 | 2024 | 36 | 0.460 |
Why?
| Somatostatin-28 | 1 | 2014 | 3 | 0.460 |
Why?
| Zinc | 2 | 2024 | 52 | 0.460 |
Why?
| Endoplasmic Reticulum Stress | 1 | 2014 | 40 | 0.460 |
Why?
| Phylogeny | 2 | 2025 | 236 | 0.460 |
Why?
| Receptors, Somatostatin | 1 | 2014 | 3 | 0.450 |
Why?
| Emulsions | 1 | 2014 | 25 | 0.450 |
Why?
| Rats | 8 | 2025 | 3292 | 0.450 |
Why?
| Calcium | 3 | 2014 | 398 | 0.440 |
Why?
| Female | 26 | 2025 | 27086 | 0.430 |
Why?
| Enhancer Elements, Genetic | 3 | 2011 | 58 | 0.430 |
Why?
| Endothelium, Vascular | 4 | 2010 | 251 | 0.430 |
Why?
| Protein Engineering | 1 | 2013 | 18 | 0.430 |
Why?
| Mesenchymal Stem Cell Transplantation | 2 | 2024 | 19 | 0.430 |
Why?
| Pancreas | 2 | 2011 | 71 | 0.410 |
Why?
| Autophagy | 2 | 2025 | 170 | 0.390 |
Why?
| Up-Regulation | 3 | 2015 | 446 | 0.390 |
Why?
| Fibrosis | 2 | 2024 | 181 | 0.380 |
Why?
| Osteoprotegerin | 3 | 2023 | 54 | 0.380 |
Why?
| Radiation, Ionizing | 4 | 2022 | 100 | 0.370 |
Why?
| Gene Expression Profiling | 3 | 2025 | 1025 | 0.360 |
Why?
| RNA, Messenger | 8 | 2025 | 1089 | 0.350 |
Why?
| Transcription Factors | 3 | 2024 | 565 | 0.320 |
Why?
| Thrombomodulin | 2 | 2008 | 27 | 0.320 |
Why?
| Mice, Knockout | 7 | 2024 | 844 | 0.310 |
Why?
| Treatment Outcome | 5 | 2025 | 5285 | 0.300 |
Why?
| Cyclic AMP Response Element-Binding Protein | 3 | 2006 | 33 | 0.280 |
Why?
| Teriparatide | 1 | 2006 | 10 | 0.270 |
Why?
| Jejunum | 2 | 2021 | 54 | 0.260 |
Why?
| Aging | 3 | 2025 | 694 | 0.250 |
Why?
| Poly I-C | 1 | 2025 | 5 | 0.250 |
Why?
| DNA-Binding Proteins | 1 | 2008 | 418 | 0.250 |
Why?
| Arthritis, Experimental | 1 | 2025 | 11 | 0.250 |
Why?
| Actin-Related Protein 2-3 Complex | 1 | 2025 | 3 | 0.240 |
Why?
| Triclosan | 1 | 2025 | 1 | 0.240 |
Why?
| Middle Aged | 7 | 2025 | 12613 | 0.240 |
Why?
| Intestine, Small | 2 | 2021 | 110 | 0.240 |
Why?
| Perceptual Masking | 1 | 2025 | 12 | 0.240 |
Why?
| Semaphorins | 1 | 2025 | 4 | 0.240 |
Why?
| Neurogenesis | 1 | 2025 | 25 | 0.240 |
Why?
| Lung | 3 | 2025 | 504 | 0.240 |
Why?
| Conjunctivitis, Allergic | 1 | 2024 | 1 | 0.240 |
Why?
| Artemisia annua | 1 | 2024 | 1 | 0.240 |
Why?
| Amino Acid Sequence | 2 | 2025 | 574 | 0.240 |
Why?
| Fatty Acids, Monounsaturated | 1 | 2024 | 10 | 0.240 |
Why?
| Methyltransferases | 1 | 2025 | 30 | 0.240 |
Why?
| Epitopes, T-Lymphocyte | 1 | 2025 | 25 | 0.240 |
Why?
| Membrane Transport Proteins | 2 | 2015 | 47 | 0.240 |
Why?
| Catechin | 1 | 2024 | 13 | 0.240 |
Why?
| Rhinitis, Allergic, Seasonal | 1 | 2024 | 8 | 0.240 |
Why?
| Anastomosis, Surgical | 1 | 2025 | 66 | 0.240 |
Why?
| Calorimetry, Differential Scanning | 1 | 2024 | 7 | 0.240 |
Why?
| Pulmonary Alveoli | 1 | 2025 | 25 | 0.240 |
Why?
| Glycolysis | 1 | 2025 | 69 | 0.240 |
Why?
| Biotechnology | 1 | 2024 | 13 | 0.240 |
Why?
| Quorum Sensing | 1 | 2024 | 9 | 0.240 |
Why?
| Endocrine Disruptors | 1 | 2025 | 32 | 0.240 |
Why?
| Drug Stability | 1 | 2024 | 35 | 0.230 |
Why?
| Time Factors | 4 | 2025 | 2935 | 0.230 |
Why?
| Crassostrea | 1 | 2024 | 2 | 0.230 |
Why?
| Maleimides | 1 | 2024 | 8 | 0.230 |
Why?
| Biphenyl Compounds | 1 | 2024 | 31 | 0.230 |
Why?
| Evoked Potentials, Auditory | 1 | 2025 | 90 | 0.230 |
Why?
| Polymers | 1 | 2024 | 39 | 0.230 |
Why?
| Mechanotransduction, Cellular | 1 | 2025 | 39 | 0.230 |
Why?
| Membrane Potential, Mitochondrial | 1 | 2024 | 36 | 0.230 |
Why?
| T-Lymphocytes, Regulatory | 1 | 2025 | 82 | 0.230 |
Why?
| Hyaluronic Acid | 1 | 2024 | 34 | 0.230 |
Why?
| Prefrontal Cortex | 1 | 2025 | 86 | 0.230 |
Why?
| Pseudomonas Infections | 1 | 2024 | 48 | 0.230 |
Why?
| Heat-Shock Proteins | 2 | 2015 | 100 | 0.230 |
Why?
| Adenosine | 1 | 2025 | 71 | 0.230 |
Why?
| Pseudomonas aeruginosa | 1 | 2024 | 72 | 0.230 |
Why?
| Adaptor Proteins, Signal Transducing | 2 | 2024 | 198 | 0.230 |
Why?
| Arthritis, Rheumatoid | 1 | 2025 | 106 | 0.230 |
Why?
| Tinnitus | 1 | 2025 | 61 | 0.230 |
Why?
| Radiation Injuries | 4 | 2010 | 112 | 0.230 |
Why?
| Kidney Tubules | 1 | 2024 | 61 | 0.230 |
Why?
| Biocompatible Materials | 1 | 2024 | 66 | 0.230 |
Why?
| Bone Regeneration | 1 | 2024 | 74 | 0.230 |
Why?
| Longevity | 1 | 2024 | 80 | 0.230 |
Why?
| Staphylococcus aureus | 2 | 2024 | 321 | 0.230 |
Why?
| Ovary | 1 | 2024 | 103 | 0.220 |
Why?
| Umbilical Cord | 1 | 2024 | 34 | 0.220 |
Why?
| Rabbits | 1 | 2024 | 372 | 0.220 |
Why?
| Periosteum | 1 | 2024 | 26 | 0.220 |
Why?
| Testosterone | 1 | 2024 | 145 | 0.220 |
Why?
| Behavior, Animal | 1 | 2025 | 178 | 0.220 |
Why?
| Lung Diseases | 1 | 2025 | 94 | 0.220 |
Why?
| Osteolysis | 1 | 2024 | 74 | 0.220 |
Why?
| Lipopolysaccharides | 1 | 2025 | 197 | 0.220 |
Why?
| Cyclophosphamide | 1 | 2024 | 168 | 0.220 |
Why?
| Mice, Inbred BALB C | 3 | 2025 | 296 | 0.220 |
Why?
| Lymphatic Vessels | 1 | 2024 | 53 | 0.220 |
Why?
| Speech Perception | 1 | 2025 | 91 | 0.220 |
Why?
| Adult | 6 | 2025 | 13584 | 0.220 |
Why?
| Graft Rejection | 1 | 2025 | 172 | 0.220 |
Why?
| Antigens, CD | 1 | 2025 | 222 | 0.220 |
Why?
| Glioblastoma | 1 | 2025 | 94 | 0.220 |
Why?
| Antihypertensive Agents | 1 | 2024 | 125 | 0.210 |
Why?
| CD4-Positive T-Lymphocytes | 1 | 2025 | 158 | 0.210 |
Why?
| Cell Proliferation | 2 | 2019 | 985 | 0.210 |
Why?
| Administration, Oral | 1 | 2024 | 434 | 0.210 |
Why?
| Cells, Cultured | 6 | 2017 | 1571 | 0.210 |
Why?
| Cyclic AMP-Dependent Protein Kinases | 2 | 2003 | 51 | 0.210 |
Why?
| Hippocampus | 1 | 2025 | 222 | 0.210 |
Why?
| Glycoproteins | 2 | 2005 | 116 | 0.210 |
Why?
| Artificial Intelligence | 1 | 2024 | 97 | 0.210 |
Why?
| Spine | 2 | 2022 | 90 | 0.210 |
Why?
| Signal Transduction | 3 | 2019 | 1624 | 0.210 |
Why?
| Glucose | 1 | 2025 | 341 | 0.210 |
Why?
| Drug Resistance, Neoplasm | 1 | 2025 | 316 | 0.210 |
Why?
| Osteomyelitis | 1 | 2024 | 128 | 0.200 |
Why?
| Kidney Transplantation | 1 | 2025 | 189 | 0.200 |
Why?
| Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 68 | 0.200 |
Why?
| Protein Binding | 4 | 2014 | 654 | 0.200 |
Why?
| Dexamethasone | 1 | 2024 | 432 | 0.200 |
Why?
| Lysosomal-Associated Membrane Protein 2 | 1 | 2022 | 4 | 0.200 |
Why?
| Cytokines | 4 | 2025 | 606 | 0.200 |
Why?
| Macrophages | 1 | 2025 | 364 | 0.200 |
Why?
| Energy Metabolism | 1 | 2024 | 286 | 0.200 |
Why?
| Indoles | 1 | 2024 | 278 | 0.190 |
Why?
| Molecular Chaperones | 1 | 2022 | 61 | 0.190 |
Why?
| Duodenum | 1 | 2021 | 35 | 0.190 |
Why?
| Brain Neoplasms | 1 | 2025 | 291 | 0.190 |
Why?
| Staphylococcal Infections | 1 | 2024 | 267 | 0.180 |
Why?
| Ileum | 1 | 2021 | 85 | 0.180 |
Why?
| Fibroblasts | 3 | 2019 | 336 | 0.180 |
Why?
| NF-kappa B | 2 | 2024 | 315 | 0.180 |
Why?
| Cyclic AMP | 2 | 2014 | 90 | 0.170 |
Why?
| Reactive Oxygen Species | 2 | 2025 | 409 | 0.170 |
Why?
| Granulocyte Colony-Stimulating Factor | 1 | 2020 | 63 | 0.170 |
Why?
| Blood Donors | 1 | 2020 | 32 | 0.170 |
Why?
| Antibodies, Viral | 1 | 2020 | 93 | 0.170 |
Why?
| CCAAT-Enhancer-Binding Protein-delta | 1 | 2019 | 22 | 0.160 |
Why?
| Hyperparathyroidism | 2 | 2011 | 31 | 0.160 |
Why?
| Prospective Studies | 1 | 2025 | 2378 | 0.150 |
Why?
| Heptanoic Acids | 2 | 2008 | 34 | 0.150 |
Why?
| Pyrroles | 2 | 2008 | 68 | 0.150 |
Why?
| Receptor Activator of Nuclear Factor-kappa B | 4 | 2006 | 33 | 0.150 |
Why?
| Gene Expression | 4 | 2014 | 610 | 0.150 |
Why?
| Phenotype | 2 | 2024 | 739 | 0.140 |
Why?
| Sulfur Dioxide | 1 | 2017 | 4 | 0.140 |
Why?
| Chlorine | 1 | 2017 | 4 | 0.140 |
Why?
| Intracellular Signaling Peptides and Proteins | 2 | 2010 | 135 | 0.140 |
Why?
| Heart Diseases | 1 | 2019 | 213 | 0.140 |
Why?
| Bone Density | 4 | 2011 | 387 | 0.140 |
Why?
| Pneumonia, Viral | 1 | 2020 | 169 | 0.140 |
Why?
| Fluorescent Dyes | 1 | 2017 | 103 | 0.130 |
Why?
| Coronavirus Infections | 1 | 2020 | 178 | 0.130 |
Why?
| Sepsis | 1 | 2019 | 225 | 0.130 |
Why?
| Obesity | 1 | 2025 | 1121 | 0.130 |
Why?
| Chemokines | 2 | 2019 | 75 | 0.130 |
Why?
| Radiotherapy | 2 | 2007 | 125 | 0.130 |
Why?
| Ovariectomy | 2 | 2014 | 115 | 0.130 |
Why?
| Percutaneous Coronary Intervention | 1 | 2019 | 300 | 0.120 |
Why?
| Diagnostic Imaging | 1 | 2017 | 181 | 0.120 |
Why?
| Blotting, Western | 2 | 2015 | 578 | 0.120 |
Why?
| Microscopy, Electron, Transmission | 1 | 2015 | 75 | 0.120 |
Why?
| Microscopy, Confocal | 1 | 2015 | 83 | 0.120 |
Why?
| Transcription Factor CHOP | 1 | 2014 | 7 | 0.120 |
Why?
| Calmodulin | 1 | 2014 | 10 | 0.120 |
Why?
| Dose-Response Relationship, Radiation | 3 | 2010 | 183 | 0.120 |
Why?
| Fermentation | 1 | 2014 | 9 | 0.110 |
Why?
| Injections, Subcutaneous | 1 | 2014 | 52 | 0.110 |
Why?
| Half-Life | 1 | 2014 | 86 | 0.110 |
Why?
| Phosphorylation | 2 | 2014 | 525 | 0.110 |
Why?
| Kinetics | 2 | 2014 | 623 | 0.110 |
Why?
| Intestinal Diseases | 2 | 2019 | 26 | 0.110 |
Why?
| Endoplasmic Reticulum | 1 | 2014 | 108 | 0.110 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2014 | 80 | 0.110 |
Why?
| Natriuretic Peptide, Brain | 1 | 2014 | 29 | 0.110 |
Why?
| Polyethylene Glycols | 1 | 2014 | 86 | 0.110 |
Why?
| Ligands | 1 | 2014 | 203 | 0.110 |
Why?
| Protein Transport | 1 | 2014 | 181 | 0.110 |
Why?
| Homeostasis | 1 | 2014 | 204 | 0.110 |
Why?
| Nerve Fibers | 1 | 2013 | 12 | 0.110 |
Why?
| Lymphatic System | 1 | 2013 | 13 | 0.100 |
Why?
| Dose-Response Relationship, Drug | 2 | 2020 | 1372 | 0.100 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2014 | 326 | 0.100 |
Why?
| Immune System | 1 | 2013 | 43 | 0.100 |
Why?
| Retrospective Studies | 1 | 2025 | 6264 | 0.100 |
Why?
| Flow Cytometry | 1 | 2015 | 474 | 0.100 |
Why?
| Core Binding Factor Alpha 1 Subunit | 3 | 2009 | 44 | 0.100 |
Why?
| Transfection | 1 | 2013 | 356 | 0.100 |
Why?
| Bone Demineralization, Pathologic | 1 | 2011 | 5 | 0.100 |
Why?
| Random Allocation | 2 | 2010 | 289 | 0.100 |
Why?
| Lactation | 1 | 2011 | 58 | 0.090 |
Why?
| Trypsin | 1 | 2011 | 12 | 0.090 |
Why?
| Pentoxifylline | 1 | 2010 | 14 | 0.090 |
Why?
| Skull | 3 | 2024 | 77 | 0.090 |
Why?
| Mice, Transgenic | 3 | 2025 | 540 | 0.090 |
Why?
| Lymph Nodes | 1 | 2013 | 257 | 0.090 |
Why?
| Transcription, Genetic | 4 | 2010 | 361 | 0.090 |
Why?
| Hematopoiesis | 1 | 2010 | 72 | 0.090 |
Why?
| Interferon-gamma | 1 | 2011 | 177 | 0.090 |
Why?
| Blood Vessels | 1 | 2010 | 71 | 0.090 |
Why?
| Base Sequence | 2 | 2014 | 639 | 0.090 |
Why?
| Molecular Sequence Data | 2 | 2014 | 778 | 0.080 |
Why?
| Radiation Dosage | 3 | 2021 | 162 | 0.080 |
Why?
| Leukocytes | 1 | 2010 | 69 | 0.080 |
Why?
| Cesium Radioisotopes | 1 | 2009 | 4 | 0.080 |
Why?
| Chemokine CXCL9 | 1 | 2009 | 7 | 0.080 |
Why?
| Thermoluminescent Dosimetry | 1 | 2009 | 7 | 0.080 |
Why?
| Bacterial Translocation | 1 | 2009 | 16 | 0.080 |
Why?
| Hydroxymethylglutaryl CoA Reductases | 1 | 2009 | 9 | 0.080 |
Why?
| Cerebellum | 1 | 2010 | 131 | 0.080 |
Why?
| Interleukin-12 | 1 | 2009 | 29 | 0.080 |
Why?
| Blood Cells | 1 | 2009 | 47 | 0.080 |
Why?
| Femur | 2 | 2024 | 130 | 0.080 |
Why?
| Cell Lineage | 1 | 2009 | 83 | 0.080 |
Why?
| rho-Associated Kinases | 1 | 2008 | 20 | 0.080 |
Why?
| Citrulline | 1 | 2009 | 102 | 0.080 |
Why?
| Plasminogen Activator Inhibitor 1 | 1 | 2008 | 6 | 0.080 |
Why?
| Brain Injuries | 1 | 2010 | 159 | 0.080 |
Why?
| Enzyme Inhibitors | 1 | 2010 | 377 | 0.080 |
Why?
| Sp1 Transcription Factor | 1 | 2008 | 22 | 0.080 |
Why?
| 14-3-3 Proteins | 1 | 2008 | 18 | 0.080 |
Why?
| Kruppel-Like Transcription Factors | 1 | 2008 | 34 | 0.080 |
Why?
| HSP90 Heat-Shock Proteins | 1 | 2008 | 51 | 0.070 |
Why?
| Kaplan-Meier Estimate | 1 | 2009 | 464 | 0.070 |
Why?
| MAP Kinase Signaling System | 1 | 2008 | 117 | 0.070 |
Why?
| Mutagenesis, Site-Directed | 1 | 2007 | 95 | 0.070 |
Why?
| Peroxynitrous Acid | 3 | 2013 | 33 | 0.070 |
Why?
| Hypolipidemic Agents | 1 | 2007 | 28 | 0.070 |
Why?
| Simvastatin | 1 | 2007 | 29 | 0.070 |
Why?
| Tissue Plasminogen Activator | 1 | 2008 | 110 | 0.070 |
Why?
| Connective Tissue | 1 | 2006 | 23 | 0.070 |
Why?
| Protein Kinase Inhibitors | 1 | 2008 | 204 | 0.070 |
Why?
| Down-Regulation | 2 | 2025 | 340 | 0.070 |
Why?
| Transcription Initiation Site | 1 | 2006 | 13 | 0.070 |
Why?
| Base Pairing | 1 | 2006 | 27 | 0.070 |
Why?
| Conserved Sequence | 1 | 2006 | 56 | 0.070 |
Why?
| Gene Deletion | 1 | 2007 | 261 | 0.070 |
Why?
| C-Reactive Protein | 1 | 2007 | 144 | 0.070 |
Why?
| Organ Specificity | 1 | 2006 | 109 | 0.070 |
Why?
| Cattle | 1 | 2006 | 205 | 0.060 |
Why?
| Binding Sites | 1 | 2006 | 362 | 0.060 |
Why?
| Fructose-Bisphosphate Aldolase | 1 | 2025 | 3 | 0.060 |
Why?
| Speech Reception Threshold Test | 1 | 2025 | 2 | 0.060 |
Why?
| Insulin-Secreting Cells | 1 | 2025 | 25 | 0.060 |
Why?
| Toxicogenetics | 1 | 2025 | 6 | 0.060 |
Why?
| HLA-DRB1 Chains | 1 | 2025 | 5 | 0.060 |
Why?
| Enzyme-Linked Immunospot Assay | 1 | 2025 | 3 | 0.060 |
Why?
| STAT1 Transcription Factor | 1 | 2025 | 26 | 0.060 |
Why?
| Transplantation Tolerance | 1 | 2025 | 5 | 0.060 |
Why?
| Young Adult | 2 | 2025 | 4107 | 0.060 |
Why?
| Bone Morphogenetic Proteins | 1 | 2005 | 57 | 0.060 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2022 | 128 | 0.060 |
Why?
| Ubiquitination | 1 | 2025 | 42 | 0.060 |
Why?
| Audiometry, Pure-Tone | 1 | 2025 | 51 | 0.060 |
Why?
| Vitis | 1 | 2024 | 3 | 0.060 |
Why?
| Noise | 1 | 2025 | 39 | 0.060 |
Why?
| Auditory Threshold | 1 | 2025 | 49 | 0.060 |
Why?
| Molecular Docking Simulation | 1 | 2025 | 73 | 0.060 |
Why?
| Organ Size | 2 | 2022 | 225 | 0.060 |
Why?
| Chick Embryo | 1 | 2024 | 83 | 0.060 |
Why?
| Acoustic Stimulation | 1 | 2025 | 93 | 0.060 |
Why?
| Porosity | 1 | 2024 | 31 | 0.060 |
Why?
| Interleukin-10 | 1 | 2025 | 84 | 0.060 |
Why?
| Food Packaging | 1 | 2024 | 7 | 0.060 |
Why?
| Tensile Strength | 1 | 2024 | 30 | 0.060 |
Why?
| Methylation | 1 | 2025 | 118 | 0.060 |
Why?
| Vascular Endothelial Growth Factor C | 1 | 2024 | 4 | 0.060 |
Why?
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2024 | 5 | 0.060 |
Why?
| Rats, Wistar | 1 | 2025 | 224 | 0.060 |
Why?
| Aquaculture | 1 | 2024 | 4 | 0.060 |
Why?
| Delayed-Action Preparations | 1 | 2024 | 56 | 0.060 |
Why?
| Superoxide Dismutase | 1 | 2025 | 116 | 0.060 |
Why?
| Hearing | 1 | 2025 | 61 | 0.060 |
Why?
| Tibia | 1 | 2025 | 119 | 0.060 |
Why?
| Xenograft Model Antitumor Assays | 1 | 2025 | 212 | 0.060 |
Why?
| Phytoplankton | 1 | 2024 | 19 | 0.060 |
Why?
| Diatoms | 1 | 2024 | 20 | 0.060 |
Why?
| Titanium | 1 | 2024 | 47 | 0.060 |
Why?
| Carcinoma, Transitional Cell | 1 | 2004 | 51 | 0.060 |
Why?
| Immunomodulation | 1 | 2024 | 36 | 0.060 |
Why?
| Water | 1 | 2024 | 76 | 0.060 |
Why?
| Seasons | 1 | 2024 | 79 | 0.060 |
Why?
| Graft Survival | 1 | 2025 | 159 | 0.060 |
Why?
| Reproduction | 1 | 2024 | 56 | 0.060 |
Why?
| Chondrocytes | 1 | 2024 | 40 | 0.060 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 2025 | 125 | 0.060 |
Why?
| Fluorocarbons | 1 | 2024 | 58 | 0.060 |
Why?
| Interleukin-6 | 1 | 2005 | 261 | 0.060 |
Why?
| Ureteral Obstruction | 1 | 2024 | 61 | 0.060 |
Why?
| Skin | 1 | 2006 | 389 | 0.060 |
Why?
| Inflammasomes | 1 | 2024 | 62 | 0.050 |
Why?
| Multienzyme Complexes | 1 | 2003 | 36 | 0.050 |
Why?
| Single-Cell Analysis | 1 | 2024 | 63 | 0.050 |
Why?
| Cysteine Endopeptidases | 1 | 2003 | 67 | 0.050 |
Why?
| Anti-Inflammatory Agents | 1 | 2024 | 163 | 0.050 |
Why?
| Tumor Microenvironment | 1 | 2025 | 222 | 0.050 |
Why?
| Liver | 1 | 2009 | 1132 | 0.050 |
Why?
| Bone and Bones | 2 | 2007 | 478 | 0.050 |
Why?
| Urinary Bladder Neoplasms | 1 | 2004 | 158 | 0.050 |
Why?
| Electroencephalography | 1 | 2025 | 308 | 0.050 |
Why?
| Epithelial Cells | 1 | 2024 | 207 | 0.050 |
Why?
| Estrenes | 1 | 2002 | 13 | 0.050 |
Why?
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2022 | 5 | 0.050 |
Why?
| Caspase 9 | 1 | 2022 | 14 | 0.050 |
Why?
| Insulin | 1 | 2025 | 467 | 0.050 |
Why?
| Receptors, Tumor Necrosis Factor | 1 | 2002 | 38 | 0.050 |
Why?
| Antibodies, Monoclonal, Humanized | 1 | 2024 | 226 | 0.050 |
Why?
| Transcription Factor AP-1 | 1 | 2002 | 62 | 0.050 |
Why?
| Proteomics | 1 | 2025 | 314 | 0.050 |
Why?
| bcl-2-Associated X Protein | 1 | 2022 | 57 | 0.050 |
Why?
| Caspase 3 | 1 | 2022 | 93 | 0.050 |
Why?
| Cell Respiration | 1 | 2022 | 41 | 0.050 |
Why?
| Calcification, Physiologic | 1 | 2022 | 40 | 0.050 |
Why?
| Sirtuin 3 | 1 | 2022 | 18 | 0.050 |
Why?
| Case-Control Studies | 1 | 2025 | 1155 | 0.050 |
Why?
| Primates | 1 | 2021 | 19 | 0.050 |
Why?
| Macaca mulatta | 1 | 2021 | 97 | 0.050 |
Why?
| HeLa Cells | 2 | 2017 | 247 | 0.050 |
Why?
| Neoplasm Proteins | 1 | 2003 | 320 | 0.050 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 572 | 0.050 |
Why?
| Cell Line, Tumor | 1 | 2025 | 1398 | 0.040 |
Why?
| Cisplatin | 1 | 2022 | 286 | 0.040 |
Why?
| Nitric Oxide Synthase | 2 | 2010 | 74 | 0.040 |
Why?
| Immunization, Passive | 1 | 2020 | 30 | 0.040 |
Why?
| Immunoglobulin M | 1 | 2020 | 58 | 0.040 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 234 | 0.040 |
Why?
| Prognosis | 1 | 2025 | 1977 | 0.040 |
Why?
| Immunoglobulin G | 1 | 2020 | 190 | 0.040 |
Why?
| Molecular Structure | 1 | 2020 | 296 | 0.040 |
Why?
| Structure-Activity Relationship | 1 | 2020 | 395 | 0.040 |
Why?
| Platelet Aggregation Inhibitors | 1 | 2019 | 174 | 0.040 |
Why?
| Endothelial Cells | 2 | 2010 | 258 | 0.040 |
Why?
| Limit of Detection | 1 | 2017 | 16 | 0.040 |
Why?
| Zebrafish | 1 | 2017 | 55 | 0.030 |
Why?
| Neoplasms | 1 | 2006 | 1255 | 0.030 |
Why?
| Child, Preschool | 1 | 2024 | 3943 | 0.030 |
Why?
| Models, Biological | 2 | 2013 | 716 | 0.030 |
Why?
| Pandemics | 1 | 2020 | 562 | 0.030 |
Why?
| Receptors, Atrial Natriuretic Factor | 1 | 2014 | 8 | 0.030 |
Why?
| Cyclic GMP | 1 | 2014 | 20 | 0.030 |
Why?
| Gene Order | 1 | 2013 | 13 | 0.030 |
Why?
| Protein Conformation | 1 | 2014 | 162 | 0.030 |
Why?
| Cell Division | 2 | 2005 | 291 | 0.030 |
Why?
| Adolescent | 1 | 2024 | 6446 | 0.030 |
Why?
| Leukocyte Count | 1 | 2013 | 69 | 0.030 |
Why?
| Nerve Endings | 1 | 2013 | 2 | 0.030 |
Why?
| Gene Targeting | 1 | 2013 | 30 | 0.030 |
Why?
| Sympathetic Nervous System | 1 | 2013 | 19 | 0.030 |
Why?
| Neurotransmitter Agents | 1 | 2013 | 34 | 0.030 |
Why?
| Child | 1 | 2024 | 6910 | 0.020 |
Why?
| Mice, 129 Strain | 1 | 2011 | 37 | 0.020 |
Why?
| Glutathione | 1 | 2013 | 299 | 0.020 |
Why?
| GTP Cyclohydrolase | 1 | 2010 | 4 | 0.020 |
Why?
| Colony-Forming Units Assay | 1 | 2010 | 25 | 0.020 |
Why?
| Drug Synergism | 1 | 2010 | 151 | 0.020 |
Why?
| Vesicular Glutamate Transport Protein 2 | 1 | 2010 | 6 | 0.020 |
Why?
| Vascular System Injuries | 1 | 2010 | 38 | 0.020 |
Why?
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2010 | 30 | 0.020 |
Why?
| Malondialdehyde | 1 | 2010 | 51 | 0.020 |
Why?
| Deoxyguanosine | 1 | 2010 | 27 | 0.020 |
Why?
| Aged | 2 | 2019 | 9743 | 0.020 |
Why?
| Bone Marrow Cells | 1 | 2010 | 196 | 0.020 |
Why?
| Core Binding Factor beta Subunit | 1 | 2009 | 3 | 0.020 |
Why?
| Imaging, Three-Dimensional | 1 | 2010 | 151 | 0.020 |
Why?
| Embryo, Mammalian | 1 | 2009 | 64 | 0.020 |
Why?
| Electrophoretic Mobility Shift Assay | 1 | 2009 | 72 | 0.020 |
Why?
| Survival Analysis | 1 | 2010 | 661 | 0.020 |
Why?
| Immunoblotting | 1 | 2009 | 115 | 0.020 |
Why?
| Analysis of Variance | 1 | 2010 | 552 | 0.020 |
Why?
| Stromal Cells | 1 | 2009 | 75 | 0.020 |
Why?
| Muscle, Smooth | 1 | 2008 | 61 | 0.020 |
Why?
| Microarray Analysis | 1 | 2008 | 70 | 0.020 |
Why?
| RNA, Small Interfering | 1 | 2009 | 208 | 0.020 |
Why?
| Vitamin D | 1 | 2009 | 87 | 0.020 |
Why?
| Tumor Suppressor Protein p53 | 1 | 2010 | 213 | 0.020 |
Why?
| Lymphoid Tissue | 1 | 2007 | 18 | 0.020 |
Why?
| Receptors, Thrombin | 1 | 2007 | 11 | 0.020 |
Why?
| Survival Rate | 1 | 2010 | 909 | 0.020 |
Why?
| Thrombin | 1 | 2007 | 36 | 0.020 |
Why?
| Protein C | 1 | 2007 | 18 | 0.020 |
Why?
| Polymerase Chain Reaction | 1 | 2008 | 449 | 0.020 |
Why?
| Abdominal Neoplasms | 1 | 2007 | 15 | 0.020 |
Why?
| Pelvic Neoplasms | 1 | 2007 | 14 | 0.020 |
Why?
| Drug Evaluation, Preclinical | 1 | 2007 | 145 | 0.020 |
Why?
| Gastrointestinal Tract | 1 | 2007 | 103 | 0.020 |
Why?
| Injections | 1 | 2005 | 57 | 0.020 |
Why?
| Histocytochemistry | 1 | 2005 | 44 | 0.020 |
Why?
| Blotting, Northern | 1 | 2005 | 110 | 0.020 |
Why?
| Genetic Markers | 1 | 2005 | 104 | 0.020 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2005 | 102 | 0.010 |
Why?
| Absorptiometry, Photon | 1 | 2005 | 156 | 0.010 |
Why?
| Drug Administration Schedule | 1 | 2005 | 370 | 0.010 |
Why?
| GTP-Binding Proteins | 1 | 2004 | 91 | 0.010 |
Why?
| Apoptosis Regulatory Proteins | 1 | 2004 | 82 | 0.010 |
Why?
| Lumbar Vertebrae | 1 | 2005 | 102 | 0.010 |
Why?
| bcl-Associated Death Protein | 1 | 2003 | 9 | 0.010 |
Why?
| Dactinomycin | 1 | 2003 | 22 | 0.010 |
Why?
| Culture Media, Conditioned | 1 | 2003 | 47 | 0.010 |
Why?
| Incidence | 1 | 2007 | 1032 | 0.010 |
Why?
| Models, Genetic | 1 | 2003 | 172 | 0.010 |
Why?
| Compressive Strength | 1 | 2002 | 12 | 0.010 |
Why?
| Dihydrotestosterone | 1 | 2002 | 12 | 0.010 |
Why?
| Seminal Vesicles | 1 | 2002 | 13 | 0.010 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2003 | 116 | 0.010 |
Why?
| Orchiectomy | 1 | 2002 | 38 | 0.010 |
Why?
| RNA | 1 | 2003 | 163 | 0.010 |
Why?
| Osteocalcin | 1 | 2002 | 43 | 0.010 |
Why?
| Uterus | 1 | 2002 | 85 | 0.010 |
Why?
| Receptors, Estrogen | 1 | 2002 | 132 | 0.010 |
Why?
| Tumor Cells, Cultured | 1 | 2002 | 457 | 0.010 |
Why?
| Pyrazoles | 1 | 2002 | 111 | 0.010 |
Why?
| Estradiol | 1 | 2002 | 221 | 0.010 |
Why?
| Osteoporosis | 1 | 2002 | 156 | 0.010 |
Why?
| Quality of Life | 1 | 2007 | 852 | 0.010 |
Why?
| Adenocarcinoma | 1 | 2004 | 396 | 0.010 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2004 | 833 | 0.010 |
Why?
| Body Weight | 1 | 2002 | 517 | 0.010 |
Why?
| Risk Factors | 1 | 2006 | 3723 | 0.010 |
Why?
| Aged, 80 and over | 1 | 2004 | 3227 | 0.010 |
Why?
| Breast Neoplasms | 1 | 2002 | 1200 | 0.010 |
Why?
|
|
Fu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|